The effects of long-term intraspinal infusion therapy with noncancer pain patients: Evaluation of patient, significant-other, and clinic staff appraisals

Neuromodulation

Volumn 2, Issue 4, 1999, Pages 241-253

  Willis, K Dean ^a   Doleys, Daniel M ^b,c  

^a Alabama Pain Center Huntsville   (United States)

^b Pain and Rehabilitation Institute   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CLONIDINE; FENTANYL; HYDROMORPHONE; MORPHINE SULFATE; OPIATE DERIVATIVE; PETHIDINE;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG INDUCED DISEASE; FAMILY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MEDICAL STAFF; PAIN ASSESSMENT; PATIENT SATISFACTION; TREATMENT OUTCOME; WORKMAN COMPENSATION;

EID: 0032699083     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.1999.00241.x     Document Type: Article

References (17)

1. Portenoy RK. Opioid therapy for chronic non-malignant pain: current status. In: Nin HL, Fields DS, Liebeskind JC eds. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle: IASP Press; 1994: 247-288.
2. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain. Report of 38 case.s Pain 1986;25:171-186.
3. Pappagallo M, Raja SN, Haytheornthwaite JA, Clark M, Campbell JN. Oral opioids in the management of postherpetic neuralgia: a prospective survey. Analgesia 1994;1:51-55.
4. Krames ES, Lanning RM. Intrathecal infusional analgesia for non-malignant pain: analgesic efficacy of intrathecal opioids with and without bupivacaine. J Pain Symptom Manage 1993;8:539-548.
5. Maron J, Loeser JD. Spinal opioid infusion in treatment of chronic pain of non-malignant origin. Clin J Pain 1996;12:174-179.
6. Krames ES, Schuchard M. Implantable intraspinal infusion analgesia: management guidelines. Pain Rev 1995;2:243-267.
7. Schuchard M, Lanning R, North R, Reig E, Krames E. Neurologic sequelae of intraspinal drug delivery systems: results of a survey of American implanters of implantable drug delivery systems. Neuromodulation 1998;1:137-148.
8. Doleys DM, Coleton M, Tutak U. Use of intraspinal infusion therapy with non-cancer pain patients: Follow up and comparison of worker's compensation versus non-worker's compensation patients. Neuromodulation 1998:1:149-159.
9. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS. Long-term intraspinal infusion of opiates in the treatment of neuropathic pain. J Pain Symptom Manage 1995;10:527-543.
10. Winkelmüller M, Winkelmüller F. Long-term effects of continuous intrathecal opioid treatment in chronic pain of non-malignant etiology. J Neurosurg 1996;85:458-467.
11. Whitehurst WR, Doleys DM, Friday N, Murray JB, Marullo DS, Haile JM. Effects of long-term chronic spinal opiate therapy in 27 non-cancer pain patients. Abstract presented American Pain Society Meetings, Orlando, Florida, November 1993.
12. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic non-cancer pain: a retrospective multi-center study. J Pain Symptom Manage 1996;11:71-80.
13. Tutak U, Doleys DM. Intrathecal infusion systems for the treatment of chronic low back and leg pain of non-cancer origin. South Med J 1996;89:295-300.
14. Brown J, Klapow J, Doleys DM, Lowery D, Tutak U. Disease-specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in non-cancer pain patients. Clin J Pain 1999;15: 122-131.
15. Barolat G, Ketcik B. He J. Long-term outcome of spinal cord stimulation for chronic pain management. Neuromodulation 1998;1:19-29.
16. Naumann C, Erdine S, Koulousakis A, Van Buyten JP, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 1999;2:92-107.
17. Physicians' Desk Reference. Montvale, NJ: Medical Economics Company, Inc.; 1999, p. 2256.